Home › Funds › DAFNA Capital Management LLC › NGEN

DAFNA Capital Management LLC position in NGEN

NERVGEN PHARMA CORP · Health Care

DAFNA Capital Management LLC reported holding 810,862 shares of NGEN (NERVGEN PHARMA CORP) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.33% of its reported portfolio and ranking #49 among its reported holdings. DAFNA Capital Management LLC has disclosed NGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)810.86K sh
Reported value held$1.55M
Portfolio Weight0.33%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's NGEN position evolved

DAFNA Capital Management LLC first disclosed a stake in NGEN in Q2 2026 at 1,050,000 shares (US$2.2M). Across 2 filings, DAFNA Capital Management LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 810,862 shares valued at US$1.5M — a reduction of -239,138 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.05M $2.16M New
Q3 2026 810.86K $1.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NGEN and 13F data

NGEN (NERVGEN PHARMA CORP) is a Health Care company. 73 other funds we track also report a position in NGEN — the largest reported positions include Empery Asset Management, LP (US$6.3M), VALLEY FORGE INVESTMENT CONSULTANTS INC ADV (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NGEN

All NGEN fund holders →

FAQ

How long has DAFNA Capital Management LLC held NGEN?

DAFNA Capital Management LLC has disclosed NGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DAFNA Capital Management LLC's current position in NGEN?

As of Q3 2026, DAFNA Capital Management LLC holds 810.86K shares of NGEN (NERVGEN PHARMA CORP), valued at $1.55M, representing 0.33% of its reported portfolio and ranking #49.

Has DAFNA Capital Management LLC been buying or selling NGEN?

In the latest 13F filing (Q3 2026), DAFNA Capital Management LLC reduced its position in NGEN.

Which other funds hold NGEN?

Other major institutional holders of NGEN include Empery Asset Management, LP, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.